NISA Investment Advisors »

Kailera Therapeutics shares owned by NISA Investment Advisors

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by NISA Investment Advisors from 13F filings

Historical chart of NISA Investment Advisors investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by NISA Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by NISA Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 871 22.03

More positions owned by NISA Investment Advisors

iShares S&P 500 Index (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Caterpillar (CAT)

View all positions for NISA Investment Advisors

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics